|
CN101679408B
(zh)
|
2006-12-22 |
2016-04-27 |
Astex治疗学有限公司 |
作为fgfr抑制剂的双环杂环化合物
|
|
HRP20151398T1
(hr)
|
2006-12-22 |
2016-02-12 |
Astex Therapeutics Limited |
Tricikliäśni derivati amina kao inhibitori protein tirozin kinaze
|
|
WO2008154642A2
(en)
|
2007-06-12 |
2008-12-18 |
Achaogen, Inc. |
Antibacterial agents
|
|
GB0720038D0
(en)
|
2007-10-12 |
2007-11-21 |
Astex Therapeutics Ltd |
New compounds
|
|
GB0720041D0
(en)
|
2007-10-12 |
2007-11-21 |
Astex Therapeutics Ltd |
New Compounds
|
|
US20110092554A1
(en)
*
|
2007-11-19 |
2011-04-21 |
Richard Chesworth |
1,3,5 tri-subtituted benzenes for treatment of alzheimer's disease and other disorders
|
|
AU2008345573B2
(en)
|
2007-12-20 |
2013-12-19 |
Envivo Pharmaceuticals, Inc. |
Tetrasubstituted benzenes
|
|
JP2011512359A
(ja)
|
2008-02-14 |
2011-04-21 |
アミラ ファーマシューティカルズ，インク． |
プロスタグランジンｄ２受容体のアンタゴニストとしての環式ジアリールエーテル化合物
|
|
JP2011518130A
(ja)
|
2008-04-02 |
2011-06-23 |
アミラ ファーマシューティカルズ，インク． |
プロスタグランジンｄ２受容体のアミノアルキルフェニルアンタゴニスト
|
|
UA103319C2
(en)
|
2008-05-06 |
2013-10-10 |
Глаксосмитклайн Ллк |
Thiazole- and oxazole-benzene sulfonamide compounds
|
|
GB0810902D0
(en)
|
2008-06-13 |
2008-07-23 |
Astex Therapeutics Ltd |
New compounds
|
|
WO2009158369A1
(en)
*
|
2008-06-25 |
2009-12-30 |
Schering Corporation |
Synthesis and use of heterocyclic antibacterial agents
|
|
PE20100094A1
(es)
|
2008-07-03 |
2010-02-18 |
Amira Pharmaceuticals Inc |
Antagonistas heteroalquilo de receptores de prostaglandina d2
|
|
US8273900B2
(en)
|
2008-08-07 |
2012-09-25 |
Novartis Ag |
Organic compounds
|
|
US8372885B2
(en)
*
|
2008-09-17 |
2013-02-12 |
Novartis Ag |
Organic compounds and their uses
|
|
US8383654B2
(en)
|
2008-11-17 |
2013-02-26 |
Panmira Pharmaceuticals, Llc |
Heterocyclic antagonists of prostaglandin D2 receptors
|
|
GB0906470D0
(en)
|
2009-04-15 |
2009-05-20 |
Astex Therapeutics Ltd |
New compounds
|
|
GB0906472D0
(en)
|
2009-04-15 |
2009-05-20 |
Astex Therapeutics Ltd |
New compounds
|
|
WO2011005355A1
(en)
*
|
2009-05-07 |
2011-01-13 |
Achaogen, Inc. |
Combinations comprising a lpxc inhibitor and an antibiotic for use in the treatment of infections caused by gram-negative bacteria
|
|
FR2950057B1
(fr)
|
2009-09-17 |
2011-08-26 |
Galderma Res & Dev |
Nouveaux composes benzene-carboxylamides, leur procede de synthese et leur utilisation en medecine ainsi qu'en cosmetique
|
|
FR2950056B1
(fr)
|
2009-09-17 |
2011-08-26 |
Galderma Res & Dev |
Nouveaux composes benzene-carboxylamides, leur procede de synthese et leur utilisation en medecine ainsi qu'en cosmetique
|
|
PH12012500734A1
(en)
|
2009-10-16 |
2012-11-26 |
Melinta Therapeutics Inc |
Antimicrobial compounds and methods of making and using the same
|
|
US9216979B2
(en)
|
2009-10-16 |
2015-12-22 |
Melinta Therapeutics, Inc. |
Antimicrobial compounds and methods of making and using the same
|
|
AU2010306646B2
(en)
|
2009-10-16 |
2016-09-01 |
Melinta Therapeutics, Inc. |
Antimicrobial compounds and methods of making and using the same
|
|
PH12012501349A1
(en)
|
2010-01-06 |
2013-01-14 |
Panmira Pharmaceuticals Llc |
Dp2 antagonist and uses thereof
|
|
PH12012502087A1
(en)
|
2010-04-20 |
2015-04-15 |
Taisho Pharmaceutical Co Ltd |
Novel hydroxamic acid derivative
|
|
US8835472B2
(en)
*
|
2010-09-02 |
2014-09-16 |
Boehringer Ingelheim International Gmbh |
Compounds, pharmaceutical compositions and uses thereof
|
|
US9738604B2
(en)
|
2010-09-03 |
2017-08-22 |
Duke University |
Ethynylbenzene derivatives
|
|
MX2013005200A
(es)
|
2010-11-10 |
2013-06-28 |
Achaogen Inc |
Derivados de acido hidroxamico y su so en el tratamiento de infecciones bacterianas.
|
|
JP6317669B2
(ja)
|
2011-04-15 |
2018-04-25 |
メリンタ セラピューティクス インコーポレイテッド |
抗菌化合物ならびにそれを作製および使用する方法
|
|
UY34305A
(es)
|
2011-09-01 |
2013-04-30 |
Novartis Ag |
Derivados de heterociclos bicíclicos para el tratamiento de la hipertensión arterial pulmonar
|
|
WO2013039947A1
(en)
|
2011-09-12 |
2013-03-21 |
Achaogen, Inc. |
Polymorphs of n-((s)-3-amino-1-(hydroxyamino)-3-methyl-1-oxobutan-2-yl)-4-(((1r,2r)-2-(hydroxymethyl)cyclopropyl)buta-1,3-diynyl)benzamide
|
|
CN102603690A
(zh)
*
|
2012-01-17 |
2012-07-25 |
凯莱英医药集团（天津）股份有限公司 |
一种一锅法制备四氢吡喃-4-甲酸及其衍生物的方法
|
|
WO2013123169A1
(en)
|
2012-02-17 |
2013-08-22 |
Millennium Pharmaceuticals, Inc. |
Pyrazolopyrimidinyl inhibitors of ubiquitin-activating enzyme
|
|
WO2013170030A1
(en)
*
|
2012-05-09 |
2013-11-14 |
Achaogen, Inc. |
Antibacterial agents
|
|
WO2013170165A1
(en)
|
2012-05-10 |
2013-11-14 |
Achaogen, Inc. |
Antibacterial agents
|
|
JP6139272B2
(ja)
*
|
2012-06-01 |
2017-05-31 |
株式会社半導体エネルギー研究所 |
発光素子の作製方法
|
|
US9073921B2
(en)
|
2013-03-01 |
2015-07-07 |
Novartis Ag |
Salt forms of bicyclic heterocyclic derivatives
|
|
WO2014165075A1
(en)
|
2013-03-12 |
2014-10-09 |
Achaogen, Inc. |
Antibacterial agents
|
|
TR201911245T4
(tr)
|
2013-03-15 |
2019-08-21 |
Fujifilm Toyama Chemical Co Ltd |
Yeni hidroksamik asit türevi veya bunun tuzu.
|
|
GB201307233D0
(en)
*
|
2013-04-22 |
2013-05-29 |
Vib Vzw |
Compounds and uses thereof
|
|
JP6378759B2
(ja)
|
2013-07-02 |
2018-08-22 |
ミレニアム ファーマシューティカルズ， インコーポレイテッドＭｉｌｌｅｎｎｉｕｍ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． |
Ｓｕｍｏ活性化酵素阻害剤として有用なヘテロアリール化合物
|
|
US9908851B2
(en)
|
2013-08-16 |
2018-03-06 |
Duke University |
2-piperidinyl substituted N,3-dihydroxybutanamides
|
|
US10189786B2
(en)
|
2013-08-16 |
2019-01-29 |
Duke University |
Antibacterial compounds
|
|
CA2921427A1
(en)
|
2013-08-16 |
2015-02-19 |
Duke University |
Substituted hydroxamic acid compounds
|
|
AU2014315045A1
(en)
|
2013-09-09 |
2016-03-24 |
Melinta Therapeutics, Inc. |
Antimicrobial compounds and methods of making and using the same
|
|
EP3039025A4
(en)
|
2013-09-09 |
2017-05-31 |
Melinta Therapeutics, Inc. |
Antimicrobial compounds and methods of making and using the same
|
|
AR097617A1
(es)
|
2013-09-13 |
2016-04-06 |
Actelion Pharmaceuticals Ltd |
Derivados antibacterianos del 2h-indazol
|
|
JPWO2015056799A1
(ja)
*
|
2013-10-18 |
2017-03-09 |
大正製薬株式会社 |
ヒドロキサム酸誘導体
|
|
JP2016210683A
(ja)
*
|
2013-10-18 |
2016-12-15 |
大正製薬株式会社 |
ヒドロキサム酸誘導体
|
|
JP2016210682A
(ja)
*
|
2013-10-18 |
2016-12-15 |
大正製薬株式会社 |
ヒドロキサム酸誘導体
|
|
TR201807881T4
(tr)
|
2013-12-19 |
2018-06-21 |
Idorsia Pharmaceuticals Ltd |
Antibakteriyel 1h-ındazol ve 1h-ındol türevleri.
|
|
US9539305B1
(en)
|
2014-03-14 |
2017-01-10 |
Fleurir Abx Llc |
Pristinamycin compositions, LpxC compositions, their improvements, and combinations thereof
|
|
JP2017515906A
(ja)
*
|
2014-05-16 |
2017-06-15 |
アクテリオン ファーマシューティカルズ リミテッドＡｃｔｅｌｉｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｌｔｄ |
抗菌性キナゾロン−４（３ｈ）−オン誘導体
|
|
ES2960601T3
(es)
*
|
2014-06-12 |
2024-03-05 |
Cedars Sinai Medical Center |
Composiciones y métodos para el tratamiento del cáncer
|
|
JP6603712B2
(ja)
|
2014-07-01 |
2019-11-06 |
ミレニアム ファーマシューティカルズ， インコーポレイテッド |
Ｓｕｍｏ活性化酵素の阻害薬として有用なヘテロアリール化合物
|
|
KR20170048546A
(ko)
|
2014-09-12 |
2017-05-08 |
토야마 케미칼 컴퍼니 리미티드 |
신규 히드록삼산 유도체 또는 그 염을 함유하는 의약 조성물
|
|
JPWO2016039432A1
(ja)
|
2014-09-12 |
2017-06-22 |
富山化学工業株式会社 |
新規なヒドロキサム酸誘導体および抗菌性物質を組み合わせて使用する方法
|
|
CN104262433B
(zh)
*
|
2014-10-11 |
2016-06-15 |
吉首大学 |
噁二唑-腺苷型化合物作为TyrRS抑制剂及其制法和用途
|
|
CN104231024B
(zh)
*
|
2014-10-11 |
2016-06-15 |
吉首大学 |
噁二唑-肌苷型化合物作为TyrRS抑制剂及其制法和用途
|
|
CN104327140B
(zh)
*
|
2014-10-11 |
2016-06-15 |
吉首大学 |
噁唑烷酮-腺苷型多靶点抗菌化合物及其制法和用途
|
|
CN104341475A
(zh)
*
|
2014-10-11 |
2015-02-11 |
吉首大学 |
利奈唑胺-腺苷型多靶点抗菌化合物及其制法和用途
|
|
CN104341476A
(zh)
*
|
2014-10-11 |
2015-02-11 |
吉首大学 |
利奈唑胺-肌苷型多靶点抗菌化合物及其制法和用途
|
|
CN105777464B
(zh)
*
|
2014-12-26 |
2020-09-29 |
中国科学院上海药物研究所 |
异羟肟酸衍生物及其制备方法和应用
|
|
JP6208161B2
(ja)
|
2015-02-06 |
2017-10-04 |
信越化学工業株式会社 |
非対称共役ジイン化合物の製造方法及びこれを用いたｚ，ｚ−共役ジエン化合物の製造方法
|
|
KR20180015114A
(ko)
|
2015-03-11 |
2018-02-12 |
멜린타 테라퓨틱스, 인크. |
항미생물 화합물 및 이의 제조 및 사용 방법
|
|
US10611747B2
(en)
|
2015-11-09 |
2020-04-07 |
Forge Therapeutics, Inc. |
Pyrone based compounds for treating bacterial infections
|
|
EP3374350B1
(en)
|
2015-11-09 |
2022-01-05 |
Forge Therapeutics, Inc. |
Hydroxypyridinone and hydroxypyrimidinone based compounds for treating bacterial infections
|
|
RU2018124788A
(ru)
*
|
2015-12-08 |
2020-01-15 |
Глэксосмитклайн Интеллекчуал Проперти Дивелопмент Лимитед |
Замещенные бензазиноны в качестве антибактериальных соединений
|
|
CN105669750B
(zh)
*
|
2016-03-01 |
2018-04-03 |
中国医学科学院医药生物技术研究所 |
新型锌离子螯合剂及其制备和在抗革兰氏阴性菌感染中的应用
|
|
MX2018010878A
(es)
|
2016-03-07 |
2018-11-09 |
Merck Sharp & Dohme |
Compuestos de aril-monobactam biciclicos y metodos de uso de los mismos para el tratamiento de infecciones bacterianas.
|
|
EP3426674A4
(en)
|
2016-03-09 |
2019-08-14 |
Blade Therapeutics, Inc. |
CYCLIC KETO AMID COMPOUNDS AS CALPAIN MODULATORS AND METHOD FOR THE PRODUCTION AND USE THEREOF
|
|
WO2017182433A1
(en)
*
|
2016-04-18 |
2017-10-26 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
Novel inhibitors of meprin alpha and beta
|
|
EP3448375B1
(en)
|
2016-04-25 |
2023-09-27 |
Duke University |
Benzoylglycine derivatives and methods of making and using same
|
|
EP3452479A1
(en)
|
2016-05-06 |
2019-03-13 |
Melinta Therapeutics, Inc. |
Antimicrobials and methods of making and using same
|
|
WO2017223349A1
(en)
|
2016-06-23 |
2017-12-28 |
Achaogen, Inc. |
Antibacterial agents
|
|
US11292801B2
(en)
|
2016-07-05 |
2022-04-05 |
Blade Therapeutics, Inc. |
Calpain modulators and therapeutic uses thereof
|
|
AU2017336523B2
(en)
|
2016-09-28 |
2022-07-21 |
Blade Therapeutics, Inc. |
Calpain modulators and therapeutic uses thereof
|
|
BR112019013016B1
(pt)
|
2016-12-23 |
2023-05-02 |
Intervet International B.V. |
Compostos antibacterianos, composição farmacêutica que os compreende e uso dos referidos compostos
|
|
AR110440A1
(es)
|
2016-12-23 |
2019-03-27 |
Intervet Int Bv |
Compuestos para el tratamiento de la enfermedad respiratoria bovina o porcina
|
|
EP3615529B1
(en)
|
2017-04-26 |
2024-06-05 |
Basilea Pharmaceutica International AG, Allschwil |
Processes for the preparation of furazanobenzimidazoles and crystalline forms thereof
|
|
US11021471B2
(en)
|
2017-05-10 |
2021-06-01 |
Forge Therapeutics, Inc. |
Antibacterial compounds
|
|
US20200095236A1
(en)
*
|
2017-05-10 |
2020-03-26 |
Forge Therapeutics, Inc. |
Antibacterial compounds
|
|
BR112020001619A2
(pt)
*
|
2017-07-27 |
2020-07-21 |
BioMendics, LLC |
tolanos substituídos para a modulação da colonização microbiana
|
|
WO2019040404A1
(en)
*
|
2017-08-21 |
2019-02-28 |
Microbiotix, Inc. |
METABOLIC-STABLE METABOLIC-N-ACYLAMINOOXADIAZOLES USEFUL AS ANTIBACTERIAL AGENTS
|
|
CA3090833A1
(en)
*
|
2018-02-10 |
2019-08-15 |
Kbp Biosciences Co., Ltd. |
Compound acting as antibiotics
|
|
CA3093802A1
(en)
|
2018-03-13 |
2019-09-19 |
Shire Human Genetic Therapies, Inc. |
Substituted imidazopyridines as inhibitors of plasma kallikrein and uses thereof
|
|
AU2019344897B2
(en)
|
2018-09-18 |
2024-01-18 |
Nikang Therapeutics, Inc. |
Tri-substituted heteroaryl derivatives AS SRC homology-2 phosphatase inhibitors
|
|
AU2019345150A1
(en)
|
2018-09-20 |
2021-05-13 |
Blacksmith Medicines, Inc. |
Antibacterial compounds
|
|
PL3873605T3
(pl)
|
2018-10-30 |
2025-03-03 |
Gilead Sciences, Inc. |
Związki hamujące integrynę alfa4beta7
|
|
WO2020092394A1
(en)
|
2018-10-30 |
2020-05-07 |
Gilead Sciences, Inc. |
Imidazopyridine derivatives as alpha4beta7 integrin inhibitors
|
|
EP3873897B1
(en)
|
2018-10-30 |
2024-08-14 |
Gilead Sciences, Inc. |
N-benzoyl-phenylalanine derivatives as alpha4beta7 integrin inhibitors for treating inflammatory diseases
|
|
DK3873884T3
(da)
|
2018-10-30 |
2025-02-17 |
Gilead Sciences Inc |
3-(quinolin-8-yl)-1,4-dihydropyrido[3,4-d]pyrimidin-2,4-dion-derivater som alpha4beta7-integrinhæmmere til behandling af inflammatoriske sygdomme
|
|
US20220081421A1
(en)
*
|
2018-11-14 |
2022-03-17 |
Forge Therapeutics, Inc. |
Antibacterial compounds
|
|
MX2021005966A
(es)
*
|
2018-11-21 |
2021-07-06 |
Taisho Pharmaceutical Co Ltd |
Nuevo derivado de imidazol.
|
|
US11578069B2
(en)
|
2019-08-14 |
2023-02-14 |
Gilead Sciences, Inc. |
Compounds for inhibition of α4 β7 integrin
|
|
US11370803B2
(en)
|
2019-09-18 |
2022-06-28 |
Takeda Pharmaceutical Company Limited |
Heteroaryl plasma kallikrein inhibitors
|
|
PL4031547T3
(pl)
|
2019-09-18 |
2024-10-07 |
Takeda Pharmaceutical Company Limited |
Inhibitory kalikreiny osoczowej i ich zastosowania
|
|
CN110563611B
(zh)
|
2019-09-19 |
2021-02-02 |
中国医学科学院医药生物技术研究所 |
一种异羟肟酸类衍生物及其制备方法和应用
|
|
WO2021138391A1
(en)
|
2019-12-30 |
2021-07-08 |
Tyra Biosciences, Inc. |
Indazole compounds
|
|
WO2021195260A1
(en)
|
2020-03-25 |
2021-09-30 |
Forge Therapeutics, Inc. |
Lpxc inhibitor and methods of making
|
|
CA3183740A1
(en)
|
2020-06-10 |
2021-12-16 |
Aligos Therapeutics, Inc. |
Anti-viral compounds for treating coronavirus, picornavirus, and norovirus infections
|
|
PE20250155A1
(es)
|
2021-06-14 |
2025-01-22 |
Scorpion Therapeutics Inc |
Derivados de la urea que pueden ser utilizados para tratar el cancer
|
|
WO2023283256A1
(en)
|
2021-07-09 |
2023-01-12 |
Aligos Therapeutics, Inc. |
Anti-viral compounds
|
|
WO2023011573A1
(zh)
*
|
2021-08-05 |
2023-02-09 |
浙江海正药业股份有限公司 |
芳香乙炔类衍生物及其制备方法和用途
|
|
WO2023043816A1
(en)
|
2021-09-17 |
2023-03-23 |
Aligos Therapeutics, Inc. |
Anti-viral compounds for treating coronavirus, picornavirus, and norovirus infections
|
|
MX2024003859A
(es)
|
2021-09-28 |
2024-05-21 |
Blacksmith Medicines Inc |
Inhibidores de lpxc y usos de estos.
|
|
MX2024007860A
(es)
*
|
2021-12-24 |
2024-07-09 |
Intervet Int Bv |
Proceso de preparacion de derivados de hidroxilamina.
|
|
WO2024067813A1
(zh)
*
|
2022-09-28 |
2024-04-04 |
浙江海正药业股份有限公司 |
芳香乙炔类衍生物及其制备方法和其医药上的用途
|
|
CN115480037B
(zh)
*
|
2022-10-14 |
2023-07-18 |
青岛国泰检测科技有限公司 |
一种污水检测方法
|
|
CN115598253B
(zh)
*
|
2022-10-25 |
2025-02-21 |
无锡紫杉药业股份有限公司 |
一种多西他赛原料药中dcc和dcu残留的检测方法
|
|
IL321433A
(en)
|
2022-12-16 |
2025-08-01 |
Astrazeneca Ab |
Purines 2,6,9 trimethylated
|
|
CN117586278A
(zh)
*
|
2023-11-27 |
2024-02-23 |
华北制药集团先泰药业有限公司 |
一种氨苄西林钠杂质及其制备方法
|
|
WO2025155681A1
(en)
*
|
2024-01-19 |
2025-07-24 |
Corteva Agriscience Llc |
Nitrification inhibiting mixtures
|